| Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium |
Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma |
| Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma |
Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer |
| Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer |
A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248 |
| Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) |
Suberoylanilide Hydroxamic Acid Vorinostat, MK0683 Versus Placebo in Advanced Malignant Pleural Mesothelioma |
| Radiation Therapy or Temozolomide in Treating Patients With Gliomas |
Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer |
| Study Evaluating SKI-606 in Philadelphia Chromosome Positive Leukemias |
Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis |
| Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated Diffuse Large B-Cell Lymphoma |
Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma |
| PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin |
Cyclophosphamide Drug Interaction Study In Cancer Patients |
| Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma |
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer |
| Reduced Intensity Conditioning Transplantation vs Standard of Care in Acute Myeloid Leukemia |
Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours |
| Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer |
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer |
| Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer |
A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer |
| Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer |
Complete Lymph Node Dissection or Observation in Treating Patients With Localized Melanoma and Sentinel Node Metastasis Who Have Undergone Sentinel Lymphadenectomy |
| Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer |
Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer |
| Cancer Vaccine Study for Unresectable Stage III Non-Small Cell Lung Cancer |
The Pharmacogenomics of Paclitaxel in Patients With Ovarian Cancer: Predictors of Toxicity and Response |
| Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy |
Gliogene: Brain Tumor Linkage Study |
| A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma |
Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases |
| Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors |
Temsirolimus Versus Sorafenib as Second-Line Therapy in Patients With Advanced RCC Who Have Failed First-Line Sunitinib |
| GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer |
A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma |
| Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-Resectable Periampullary Cancer |
Bortezomib and High-Dose Melphalan at Myeloma Relapse |
| Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer |
A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer |
| Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Eval. of the Efficacy of Ridaforolimus) |
NOPHO ALL-2008 Pilot Study on Consolidation Therapy for Children and Adolescents With Acute Lymphoblastic Leukemia |
| Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer |
ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer |
| Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in theTreatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen |
HuMax-CD38 Safety Study in Multiple Myeloma |
| A Dose-Escalating Study of R7159 Monotherapy in Patients With CD20+ Malignant Disease |
Treatment of Patients With PTLD Using a Sequential Treatment of Rituximab and CHOP-Based Chemotherapy |
| Phase I/II Combination With Irinotecan- Erbitux |
Chemotherapy and Avastin Followed by Maintenance Treatment With Avastin +/- Tarceva |
| Molecular Markers in Treatment in Endometrial Cancer |
European Registry for Newly Diagnosed Patients With Myelodysplastic Syndromes of IPSS Low and Intermediate-1 Subtypes |
| Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma |
Study of MK0646 in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer |
| A Phase III Trial of ZD4054 (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer |
A Study to Determine the Activity of SCH 717454 in Subjects With Relapsed Osteosarcoma or Ewing's Sarcoma (Study P04720AM3) |
| Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer |
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab |
| A Phase III Trial of ZD4054 (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer |
Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma |
| Early Reversal of Defunctioning Stoma Trial |
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma |
| Alemtuzumab and CHOP in T-cell Lymphoma |
Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG-2402 |
| FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS Tumor |
Correlative Biomarker Study in Patients With Myeloproliferative Disorders |
| Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Colon Cancer Stage Dukes' C |
Sunitinib Plus Prednisone In Patients With Metastatic Hormone-Refractory Prostate Cancer After Failure Of Docetaxel Chemotherapy |
| Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer |
Randomized Placebo Controlled Trial of Budesonide-MMX™ 6 mg and 9 mg in Patients With Ulcerative Colitis |
| Safety Study of Denosumab in Subjects With Recurrent or Unresectable Giant Cell Tumor of Bone |
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma |
| RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe |
Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma |
| Lanreotide as Primary Treatment for Acromegalic Patients With Pituitary Gland Macroadenoma |
Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM) |
| Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy |
A Phase III Study of Alpharadin (Radium-223)in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases |
| Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer |
A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer |
| Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib |
Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer |
| TaxXel: Taxotere and Xeloda in Esophageal Cancer |
Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment |
| This is a Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM. |
Randomized Study Comparing the Effect of Dasatinib and Imatinib on Malignant Stem Cells in Chronic Myeloid Leukemia |
| A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer |
Efficacy Study of XL184 in Adults With Medullary Thyroid Cancer |
| Study Evaluating HKI-272 in Combination With Vinorelbine in Subjects With Solid Tumors and Metastatic Breast Cancer |
A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer |
| Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma |
Tranexamic Acid in Surgery of Advanced Ovarian Cancer |
| Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer |
Ofatumumab + Chlorambucil vs. Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia |
| A Randomized Double Blind Phase III Trial of Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy |
High Dose, Absorbed Dose Adjusted 90Y-ibritumomab With PBSC Support in B-cell Lymphoma |
| Health Economic Evaluation of Primovist-enhanced Liver MRI |
Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer |
| AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer |
A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer |
| A Scandinavian Sarcoma Group Protocol for Patients With High-Risk Soft Tissue Sarcoma of the Extremities and Trunk Wall |
Haploidentical Stem Cell Transplantation in Neuroblastoma |
| A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor |
A Study of Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC) |
| Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients |
|
